The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials

Peer Review reports

Original Submission
4 Nov 2023	Submitted	Original manuscript
25 Nov 2023	Reviewed	Reviewer Report
8 Dec 2023	Reviewed	Reviewer Report - Vivek Kumar
4 Feb 2024	Author responded	Author comments - Amirhossein Sahebkar
Resubmission - Version 2
4 Feb 2024	Submitted	Manuscript version 2
Publishing
6 Feb 2024	Editorially accepted
23 Feb 2024	Article published	10.1186/s40360-024-00740-y

Back to article page